These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17597400)

  • 1. Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.
    Perez-Calle JL; Marin-Jimenez I; Lopez-Serrano P; Gisbert JP; Pena AS; Fernandez-Rodriguez C
    Dig Dis Sci; 2008 Feb; 53(2):486-9. PubMed ID: 17597400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V; Iglesias-Flores E; González R; Gisbert JP; Gallardo-Valverde JM; González-Galilea A; Naranjo-Rodríguez A; de Dios-Vega JF; Muntané J; Gómez-Camacho F
    J Crohns Colitis; 2010 Jun; 4(2):144-52. PubMed ID: 21122498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: a potential diagnostic pitfall.
    Naymagon S; Mikulasovich M; Gui X; Ullman TA; Harpaz N
    J Crohns Colitis; 2014 Jul; 8(7):635-40. PubMed ID: 24368253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation.
    Matsui T; Yao T; Sakurai T; Yao K; Hirai F; Matake H; Tsuda S; Wada Y; Iwashita A; Kamachi S
    J Gastroenterol; 2003; 38(7):647-55. PubMed ID: 12898357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
    Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
    Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.
    Parente JM; Coy CS; Campelo V; Parente MP; Costa LA; da Silva RM; Stephan C; Zeitune JM
    World J Gastroenterol; 2015 Jan; 21(4):1197-206. PubMed ID: 25632193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
    Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
    Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease, ulcerative colitis or indeterminate colitis--how important is it to differentiate?
    Geboes K
    Acta Gastroenterol Belg; 2001; 64(2):197-200. PubMed ID: 11475135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum macromolecular creatine kinase type 1 as a diagnostic clue in inflammatory bowel disease?
    Hoffmann KM; Grillitsch M; Deutschmann A; Högenauer C; Stojakovic T; Hauer AC
    Eur J Pediatr; 2013 May; 172(5):699-701. PubMed ID: 23328962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
    Parente F; Cucino C; Bollani S; Imbesi V; Maconi G; Bonetto S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.
    Zissimopoulos A; Vradelis S; Konialis M; Chadolias D; Bampali A; Constantinidis T; Efremidou E; Kouklakis G
    Scand J Gastroenterol; 2014 Aug; 49(8):942-9. PubMed ID: 24897131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients.
    Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P
    World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.